Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

San-tai Song

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 18, 2011
[Practice and consideration on the salvage treatment of advanced breast cancer]San-tai Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 30, 2010
[Practice and consideration on neoadjuvant therapy for early breast cancer]San-tai Song
Zhonghua Yi Xue Za Zhi|April 10, 2007
[Efficacy in advanced breast cancer should be evaluated by time to progression]San-Tai Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 29, 2005
[Aromatase inhibitors in the treatment of breast cancer: current status and some problems]San-tai Song, Zhe-fei Jiang
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 28, 2006
[Current status of the study of the mechanism of epidermal growth factor receptor targeting drug therapy and their related markers]Yan Wang, Jian-ming Xu, San-tai Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 11, 2005
[Recent advances in the study of autologous hematopoietic stem cell purging]Shi-kai Wu, Chen Lin, San-tai Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 1, 2006
[Basic Consensus on endocrinotherapy for breast cancer]Ze-fei Jiang, Bing-he Xu, San-tai Song
Acta Pharmacologica Sinica|April 5, 2003
Advancements of antisense oligonucleotides in treatment of breast cancerShuan-Ping Yang, San-Tai Song, Hai-Feng Song
Zhonghua Yi Xue Za Zhi|December 6, 2005
[New evidence and clinical practice of modern breast cancer treatment]Ze-fei Jiang, Kai-tai Yao, San-tai Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|March 10, 2010
[Expression of Gemcitabine-resistance-related gene and polymorphism of ribonucleotide reductase M1 gene promoter in Gemcitabine-resistant A549/Gem and NCI-H460/Gem cell lines]Xiao-qing Liu, Wei-xia Wang, Li Lin, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 18, 2011
[Practice and consideration on the salvage treatment of advanced breast cancer]San-tai Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 30, 2010
[Practice and consideration on neoadjuvant therapy for early breast cancer]San-tai Song
Zhonghua Yi Xue Za Zhi|April 10, 2007
[Efficacy in advanced breast cancer should be evaluated by time to progression]San-Tai Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 29, 2005
[Aromatase inhibitors in the treatment of breast cancer: current status and some problems]San-tai Song, Zhe-fei Jiang
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 28, 2006
[Current status of the study of the mechanism of epidermal growth factor receptor targeting drug therapy and their related markers]Yan Wang, Jian-ming Xu, San-tai Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 11, 2005
[Recent advances in the study of autologous hematopoietic stem cell purging]Shi-kai Wu, Chen Lin, San-tai Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 1, 2006
[Basic Consensus on endocrinotherapy for breast cancer]Ze-fei Jiang, Bing-he Xu, San-tai Song
Acta Pharmacologica Sinica|April 5, 2003
Advancements of antisense oligonucleotides in treatment of breast cancerShuan-Ping Yang, San-Tai Song, Hai-Feng Song
Zhonghua Yi Xue Za Zhi|December 6, 2005
[New evidence and clinical practice of modern breast cancer treatment]Ze-fei Jiang, Kai-tai Yao, San-tai Song
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|March 10, 2010
[Expression of Gemcitabine-resistance-related gene and polymorphism of ribonucleotide reductase M1 gene promoter in Gemcitabine-resistant A549/Gem and NCI-H460/Gem cell lines]Xiao-qing Liu, Wei-xia Wang, Li Lin, et al.
Pageof 6